Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

Soria-Juan, Bárbara; Escacena, Natalia; Capilla-González, Vivian; Aguilera, Yolanda; Llanos, Lucía; Tejedo, Juan-R; Bedoya, Francisco-J; Juan, Verónica; de-la-Cuesta, Antonio; Ruiz-Salmerón, Rafael; Andreu, Enrique; Grochowicz, Lukas; Prósper, Felipe; Sánchez-Guijo, Fermín; Lozano, Francisco-S; Miralles, Manuel; Del-Río-Solá, Lourdes; Castellanos, Gregorio; Moraleda, José-M; Sackstein, Robert; García-Arranz, Mariano; García-Olmo, Damián; Martín, Franz; Hmadcha, Abdelkrim; Soria, Bernat

RICSMUR Principal
→
02. Servicio Murciano de Salud (SMS)
→
02.01. Área de Salud I Murcia Oeste
→
02.01.01. Investigación y comunicación científica
→
Ver ítem

dc.contributor.author	Soria-Juan, Bárbara
dc.contributor.author	Escacena, Natalia
dc.contributor.author	Capilla-González, Vivian
dc.contributor.author	Aguilera, Yolanda
dc.contributor.author	Llanos, Lucía
dc.contributor.author	Tejedo, Juan-R
dc.contributor.author	Bedoya, Francisco-J
dc.contributor.author	Juan, Verónica
dc.contributor.author	de-la-Cuesta, Antonio
dc.contributor.author	Ruiz-Salmerón, Rafael
dc.contributor.author	Andreu, Enrique
dc.contributor.author	Grochowicz, Lukas
dc.contributor.author	Prósper, Felipe
dc.contributor.author	Sánchez-Guijo, Fermín
dc.contributor.author	Lozano, Francisco-S
dc.contributor.author	Miralles, Manuel
dc.contributor.author	Del-Río-Solá, Lourdes
dc.contributor.author	Castellanos, Gregorio
dc.contributor.author	Moraleda, José-M
dc.contributor.author	Sackstein, Robert
dc.contributor.author	García-Arranz, Mariano
dc.contributor.author	García-Olmo, Damián
dc.contributor.author	Martín, Franz
dc.contributor.author	Hmadcha, Abdelkrim
dc.contributor.author	Soria, Bernat
dc.date.accessioned	2025-12-03T10:46:30Z
dc.date.available	2025-12-03T10:46:30Z
dc.date.issued	2020
dc.identifier.citation	Soria-Juan B, Escacena N, Capilla-González V, Aguilera Y, Llanos L, Tejedo JR, et al. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus. Front Immunol. 2 de septiembre de 2020;11:2029.
dc.identifier.issn	1664-3224
dc.identifier.uri	https://sms.carm.es/ricsmur/handle/123456789/22850
dc.description.abstract	[This corrects the article DOI: 10.3389/fimmu.2019.01151.].
dc.language.iso	eng
dc.publisher	Frontiers Media S.A.
dc.rights	Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri	https://creativecommons.org/licenses/by-nc-nd/4.0	*
dc.title	Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)
dc.type	info:eu-repo/semantics/article
dc.identifier.pmid	32983148
dc.relation.publisherversion	https://www.frontiersin.org/article/10.3389/fimmu.2020.02029/full
dc.identifier.doi	10.3389/fimmu.2020.02029
dc.journal.title	Frontiers In Immunology